Healthy Extracts Inc Stock Price, News & Analysis

Healthy Extracts (OTCQB:HYEX) was invited to present at the Trickle Research Microcap Conference on November 13, 2025 at Topgolf Centennial in Centennial, Colorado, with a live stream scheduled and a 3:06 p.m. Mountain time presentation.

Management will review the company platform, recent merger with Gummy USA completed in early October, and product growth: Q3 2025 net revenue expected +23% YoY, direct-to-consumer subscriptions +58%, Amazon Subscribe & Save orders +98%, and a 6 million gummy follow-on order contributing to a projected record Q4 and full year.

Healthy Extracts (OTCQB:HYEX) expects Q3 2025 net revenue of ~ $920,000, up 23% year-over-year and the highest third-quarter result on record.

Subscription growth drove results: Amazon "Subscribe & Save" customers rose 98% and direct-to-consumer subscriptions rose 58%. The company completed a merger with Gummy USA effective at the start of Q4 and announced a follow-on order for 6 million nutraceutical gummies expected to significantly boost Q4 revenue. New product launches in Q3 expanded categories to include sleep and gut health. Results are preliminary, unaudited and subject to revision ahead of the official Q3 report in November.

Healthy Extracts (OTCQB: HYEX) announced that its Gummy USA subsidiary received a 6 million gummy follow-on order for a proprietary women's formulation, scheduled to ship within four weeks. The gummies target hormonal-balance symptoms such as missed periods, acne, excess hair growth, infertility and weight gain and were developed with client medical advisors. Gummy USA cites selection over competitors for superior texture and flavor with challenging ingredients and says its HACCP, GMP-certified, FDA-registered facility is scaling to meet rising private-label demand. The company references a recent merger integrating R&D, manufacturing, distribution and sales.

Healthy Extracts (OTCQB:HYEX) announced significant developments following its merger with Gummy USA, as discussed by new CEO Don Swanson in a Money Channel interview. The merger integrates Gummy USA's proprietary SureDose™ technology with Healthy Extracts' product development and marketing platform.

The company reported strong financial performance with net revenues up 20% in H1 2025. Notable growth metrics include 88% increase in direct-to-consumer subscriptions and 107% growth in Amazon Subscribe & Save customers. The merger is expected to accelerate growth by over 50% in the coming year.

Healthy Extracts (OTCQB:HYEX), a nutraceutical technology company, will present at the ArcStone-Kingswood Growth Summit 2025 in Toronto on September 18, 2025. The company will showcase its strong financial performance, including a 20% increase in net revenues during H1 2025, driven by significant growth in subscription-based revenue with direct-to-consumer subscriptions up 88% and Amazon Subscribe & Save customers increasing 107% year-over-year.

The presentation will highlight their recent merger with Gummy USA, featuring the proprietary SureDose™ technology for precision-dosed nutraceutical gummies, and their new functional drinking straw technology launched through Whitney Johns Nutrition. The company maintains a top three category ranking on Amazon.com.

Healthy Extracts (OTCQB:HYEX) has launched two groundbreaking wellness products in North America: Hydrate EZ™ and Mynus Sugar™, featuring Gelteq's (NASDAQ:GELS) proprietary gel-based delivery system. Both products come in innovative 2-oz gel packs with no mixing required.

The company reported 20% revenue growth in H1 2025 and recently completed a transformative merger with Gummy USA, which is expected to accelerate growth by over 50%. The new products target significant market opportunities, with the hydration supplement market projected to reach $4.4 billion by 2034 and the carb blocker market expected to hit $2.5 billion by 2033.

The launch follows a distribution agreement with Gelteq announced in June, establishing HYEX as the operational backbone for Gelteq's products in North America. Products are available through Bergametna.com and Amazon, with promotional discounts of up to 20% for subscribers.

Healthy Extracts (OTCQB:HYEX) reported strong Q2 2025 results with record net revenue of $969,000, up 7% year-over-year, and increased its 2025 revenue guidance by 50% to $6.3 million+. The company achieved a gross profit margin of 61.2% and net income of $67,000 ($0.02 per share).

The quarter featured significant operational developments, including the launch of new products STAT10 for heart health, 4Sleep for better rest, and the WHITNEY JOHNS Gut Health Straw. Most notably, HYEX completed a transformative merger with Gummy USA, adding a HACCP, GMP-certified manufacturing facility expected to contribute up to $2.1 million in revenue in H2 2025.

Direct-to-consumer metrics showed remarkable growth with product subscriptions up 88% and Amazon "Subscribe & Save" customers increasing 107%. The company maintains a top three category ranking on Amazon.com and expanded partnerships with Gelteq Limited and Lelantos Fibre.

Healthy Extracts (OTCQB:HYEX) has acquired Gummy USA, a Florida-based precision-dosed nutraceutical gummies manufacturer, in an all-stock transaction. The acquisition brings HACCP, GMP-certified, and FDA-registered manufacturing in-house, with production capacity scalable to $20 million in annual revenue.

The deal is projected to generate up to $7 million in additional annualized revenue in 2025, with the company expecting to reach an overall annualized revenue run rate exceeding $11.5 million by year-end. Gummy USA founder Don Swanson has been appointed president and chairman, while Duke Pitts continues as CEO.

The strategic acquisition adds a third specialized product marketing channel alongside existing gel-packs and functional drinking straws, enhancing vertical integration and expanding the company's IP portfolio. The facility is expected to generate $3.5 million in revenue in H2 2025, with potential to reach full capacity in 2026.

Healthy Extracts (OTCQB:HYEX), a nutraceutical company, reported preliminary Q2 2025 results with expected record net revenue exceeding $970,000, up 8% year-over-year. The company anticipates adjusted EBITDA of nearly $100,000, driven by strong marketing and distribution performance.

Key highlights include a 107% increase in Amazon "Subscribe & Save" customers and 88% growth in Direct-to-Consumer subscriptions. The company launched three new product formulations in sleep and gut health categories, maintaining its top three Amazon ranking. HYEX also established an exclusive logistics agreement with Gelteq for North America.

Management increased 2025 revenue guidance to $4.2 million, representing 34% growth over 2024, supported by new product launches and expanding market channels.